 Indian Express | USFDA approves safer diabetes drug which acts on kidneys Indian Express A novel anti-diabetic drug that lowers blood glucose levels by acting on the kidneys, instead of the liver or the pancreas, has been approved by the USFDA. The drug, Invokana (Canagliflozin), works by blocking the reabsorption of glucose by the kidney, ... |
